Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediates Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115851559A reveals a novel recombinant E. coli route for 3,4-DHBA. Discover cost-effective biosynthesis solutions and supply chain advantages for chiral intermediates.
Patent CN106520896B reveals one-step fermentation for 8DM. Enhances yield and reduces solvent use for reliable pharmaceutical intermediates supply chains.
Patent CN102190642A reveals a scalable Prins reaction route for high-purity Corey lactone, offering significant cost reduction in prostaglandin manufacturing.
Patent CN113462728A details a novel whole-cell biocatalytic route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN111253275A reveals a mild Cu-catalyzed N-demethylation method. Discover cost-effective synthesis routes for high-purity pharmaceutical intermediates.
Novel copper-catalyzed method for amide N-demethylation using NFSI. Offers mild conditions and high yields for API intermediates.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Novel tetrapeptide-catalyzed asymmetric Aldol synthesis for high-purity pharmaceutical intermediates. Cost-effective route to pantolactone with superior enantioselectivity.
Discover the advanced preparation method for high-purity allyl benzenesulfonate via patent CN114409574A. Achieve superior yields and cost-effective production for fine chemical applications.
Patent CN115894525A reveals a novel cyclization method yielding >99.9% purity intermediates, offering significant cost and supply chain advantages for global pharma manufacturers.
Patent CN113249417B reveals a biocatalytic route for chiral cis-beta-aryl-beta-hydroxy-alpha-amino esters using KRED-Bt, offering high stereoselectivity and industrial scalability.
Patent CN113200899A details a novel one-pot FeCl3-catalyzed synthesis of aryl selenides, offering high yields and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113004236B reveals a green POMs-catalyzed route for 3-methylenebenzofuran-1(3H)-ones, offering high yields and reduced costs for API manufacturing.
Patent CN114773309A details a high-yield synthesis of Hepatitis C intermediates using Lewis acid catalysis, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel chiral phosphonous bis-amino-oxazoline copper complex enables 98% yield in Henry reactions, offering reliable pharmaceutical intermediate supply.
Patent CN112300061B details a novel Ru-catalyzed C-H acylation method using amides, offering a cost-effective and scalable route for high-purity pharmaceutical intermediates.
Patent CN100336803C details a scalable resolution method for difluorophenylalanine, offering high purity and cost-effective supply chain solutions for pharma.
Discover the advanced continuous flow synthesis of (3aS,6aR)-lactone per patent CN114560865A. Achieve >99% ee and >90% yield with reduced costs and enhanced supply reliability for biotin production.
Patent CN105543186A reveals novel biocatalytic route for high-purity chiral alcohols. Enables cost reduction in chiral alcohol manufacturing and supply chain reliability.
Novel KmAKR mutants enable high-yield enzymatic synthesis of rosuvastatin side chains, offering superior stability and cost-effective manufacturing solutions.